1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
2. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of Generic Drugs, Rockville, Maryland.
3. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Silver Spring, Maryland.
4. GlaxoSmithKline R&D, Stockley Park, Uxbridge, United Kingdom.
5. Pfizer Global Research and Development, Sandwich, Kent, United Kingdom.
6. University of Florida, Gainesville, Florida.
7. Cetero Research, Cary, North Carolina.
8. Scientific Consultant, Rudolstadt, Germany
9. Novartis Parmaceuticals, East Hanover, New Jersey.
10. GlaxoSmithKline, Research Triangle Park, North Carolina.
11. Drinker, Biddle, and Reath, Washington, DC.
12. Scientific Consultant, Norfolk, United Kingdom.
13. Vectura Limited, Chippenham, United Kingdom.
14. Novartis Pharmaceuticals, Horsham, United Kingdom.
15. Virginia Commonwealth University, Richmond, Virginia.
16. Poochikian Pharma Consulting, Rockville, Maryland.
17. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology, Silver Spring, Maryland.
18. Teva Pharmaceuticals, North Wales, Pennsylvania.
19. Axar Pharmaceuticals, Irvine, California.
20. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Pharmaceutical Science, Office of New Drug Quality Assessment, Silver Spring, Maryland.